Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine—which designs nanotechnology-based ...

Tamoxifen is a nonsteroidal triphenylethyl compound that is widely used as adjuvant therapy in the treatment of breast cancer. Tamoxifen prolongs overall and disease-free survival, reduces the ...